ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

オクスプレノロール

Oxprenolol

HCID 4631
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
6452-71-7
標準SMILES
C=CCOc1ccccc1OCC(O)CNC(C)C
InChIKey
CEMAWMOMDPGJMB-UHFFFAOYSA-N
分子式
C15H23NO3
平均分子量
265.35 g/mol
単同位体質量
265.1677936

概要

1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)-2-propanol is an aromatic ether.

名称と識別子

優先名称
Oxprenolol
IUPAC
1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol
現地名
オクスプレノロール
英語名
oxprenolol
分子式
C15H23NO3
分子量
265.35

名称と別名

oxprenolol6452-71-7CoretalOxprenololum519MXN9YZRDTXSID10438352-Propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-2-Propanol, 1-[(1-methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-{2-hydroxy-3-[2-(prop-2-en-1-yloxy)phenoxy]propyl}(propan-2-yl)amineoxprenololo(2-hydroxy-3-(2-(prop-2-en-1-yloxy)phenoxy)propyl)(propan-2-yl)amineTrasicor, Slow
名称をさらに表示
1-[o-(アリルオキシ)フェノキシ]-3-イソプロピルアミノ-2-プロパノールオクスプレノロール1-[2-(アリルオキシ)フェノキシ]-3-(イソプロピルアミノ)-2-プロパノールコレタールオキシプレノロール1-[(1-メチルエチル)アミノ]-3-[2-(2-プロペニルオキシ)フェノキシ]-2-プロパノール1-(2-アリルオキシフェノキシ)-3-(イソプロピルアミノ)-2-プロパノール1-(イソプロピルアミノ)-3-[2-(2-プロペニルオキシ)フェノキシ]-2-プロパノールTevacorOxenalolAids001596Aids-001596Oxprenolol-d7oxprenolol USP/EP/BPCoretal (hydrochloride)1-(2-allyloxyphenoxy)-3-isopropylaminopropan-2-ol
RefChem:857811DTXCID9023835C07AA02229-257-9245-359-6dl-Oxprenolol(+-)-OxprenololOsprenololo [DCIT]

データベース識別子

CAS
6452-71-7
PubChem CID
4631
DTXSID
DTXSID1043835
ChEMBL
CHEMBL546
ChEBI
CHEBI:91704
UNII
519MXN9YZR
EC Number
229-257-9
Nikkaji
J318.375K、J8.410G

物性

構造計算による物性補完中

XLogP
2.1
極性表面積
50.7 Ų
水素結合供与体数
2
水素結合受容体数
4
回転可能結合数
9
重原子数
19
形式電荷
0
複雑度
246

実験および物理化学的性質

Chemical ClassesOther Uses -> Pharmaceuticals
Drugs · 2 件

Pharmaceuticals

Pharmaceuticals -> Antihypertensives

LogP · 2 件

2.10

2.25

Solubility6.80e-01 g/L
Human DrugsPharmaceuticals
Physical DescriptionSolid
Dissociation Constants9.57
Collision Cross Section161.7 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

物理化学的性質

融点
78 · 78-80°
沸点
408.57 °C · 408.57°C (rough estimate)
比重(密度)
1.0479 · 1.0479 (rough estimate)
屈折率
1.5 · 1.5000 (estimate)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P262, P264, P270, P271, P280, P301+P316, P302+P352, P304+P340, P316, P321, P330, P361+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

危険有害性情報

Regulatory Information2-Propanol, 1-(1-methylethyl)amino-3-2-(2-propenyloxy)phenoxy-: Does not have an individual approval but may be used under an appropriate group standard
Hazards SummaryAllergic contact dermatitis reported in a pharmaceutical worker; [Kanerva, p. 1822] See Propranolol.
Hazard Classes and CategoriesAcute Tox. 3 (100%)

毒性情報

Adverse EffectsSkin Sensitizer - An agent that can induce an allergic reaction in the skin.

安全データ

危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード H301

化学と産業

薬理情報

ATC Code · 2 件

C - Cardiovascular system

QC - Cardiovascular system

Pharmacodynamics · 1 件

Oxprenolol is a non-selective beta blocker with some intrinsic sympathomimetic activity. Oxprenolol is a lipophilic molecule and hence, it is able to cross the blood-brain barrier. As such, it is associated with a higher incidence of CNS-related side effects than hydrophilic ligands such as atenolol, sotalol and nadolol. Oxprenolol is an potent beta-blocker and should not be administered to asthmatics because it can cause irreversible airway failure and inflammation.

Mechanism of Action · 1 件

Like other beta-adrenergic antagonists, oxprenolol competes with adrenergic neurotransmitters such as catecholamines for binding at sympathetic receptor sites. Like propranolol and timolol, oxprenolol binds at beta(1)-adrenergic receptors in the heart and vascular smooth muscle, inhibiting the effects of the catecholamines epinephrine and norepinephrine and decreasing heart rate, cardiac output, and systolic and diastolic blood pressure. It also blocks beta-2 adrenergic receptors located in bronchiole smooth muscle, causing vasoconstriction. By binding beta-2 receptors in the juxtaglomerular apparatus, oxprenolol inhibits the production of renin, thereby inhibiting angiotensin II and aldosterone production. Oxprenolol therefore inhibits the vasoconstriction and water retention due to angiotensin II and aldosterone, respectively.

Biological Half-Life1-2 hours
Metabolism/Metabolites · 2 件

Hepatic.

Oxoprenolol has known human metabolites that include Oxprenolol glucuronide.

MeSH Pharmacological Classification · 6 件

Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

関連反応

1 件
反応記録を作成
HRID 328893 の反応式
HRID 328893生成物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
溶解性
Dichloromethane (Slightly), Methanol (Slightly)
外見
Solid
酸解離定数(Pka)
13.89 · 13.89±0.20(Predicted)
色
White to Off-White
安定性
Stable under recommended storage conditions., Stable Under Recommended Storage C

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.

Drugs used to cause dilation of the blood vessels.

Absorption, Distribution and ExcretionOral bioavailability is 20-70%.
Cellular LocationsMembrane
Metabolite PathwaysOxprenolol Action Pathway

用途と製造

Uses · 2 件

Used as a beta-blocking agent; [Kanerva, p. 1822]

Use (kg; approx.) in Germany (2009): >50

Use ClassificationPharmaceuticals

応用分野

説明Oxprenolol induced contact dermatitis in a worker at a pharmaceutical plant, in the division for drug synthesis. Epichlorhydrin was also used for the production of both propranolol and oxprenolol.

使用Oxprenolol is a free base of Oxprenolol Hydrochloride(O870500) which is a β-Adrenergic blocker. Antihypertensive, antianginal, antiarrhythmic.

上流・下流製品情報

上流原料

イソプロピルアミンエピクロロヒドリン